Paper Details

  1. Home
  2. Paper Details

[The problems of prophylactic chemotherapy, the second-look operation and the maintenance of the remission in the treatment of ovarian cancer (author's transl)].

Author: PfleidererA

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

A review of 1022 ovarian cancer cases found that post-operative prophylactic chemotherapy was beneficial in stages 1 and 2, but only for cases with tumor cells in secretions or ascites, or with known chemotherapy sensitivity. Cyclophosphamide led to remission in about 50% of inoperable stage 3 cases. Radical surgery during remission and continuous chemotherapy for at least 2 years after surgery and radiation are vital for long-term survival.
Paper Details　
Original Abstract of the Article :
The results of the treatment of 1022 ovarian cancers were reviewed and the problems of prophylactic chemotherapy, a second look operation and the maintenance of the remission were studied. In ovarian cancers of stage 1 and stage 2, a post-operative prophylactic chemotherapy is useful only in cases w...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/1254157

データ提供：米国国立医学図書館（NLM）

Navigating Ovarian Cancer: A Journey Through Treatment Options

Ovarian cancer is a challenging disease, and its treatment often involves a multifaceted approach. This study explores the use of prophylactic chemotherapy, second-look operations, and maintenance therapy in managing ovarian cancer. The authors provide insights into the effectiveness of these approaches and highlight the importance of individualized treatment strategies.

Ovarian Cancer Treatment: A Balancing Act

The study emphasizes the need for a tailored approach to ovarian cancer treatment, considering factors such as stage of the disease, tumor characteristics, and patient response. The authors discuss the role of prophylactic chemotherapy, second-look operations, and maintenance therapy in managing different stages of the disease. It's like navigating a desert with varying terrain, requiring different strategies to overcome the challenges and reach the desired destination.

Optimizing Outcomes: A Multifaceted Approach

The study underscores the importance of a multi-faceted approach to ovarian cancer treatment, combining surgery, chemotherapy, and other therapies. It highlights the need for ongoing research to develop new and effective treatments, improving the survival rates and quality of life for patients with ovarian cancer. It's a collaborative journey towards conquering ovarian cancer, requiring a multifaceted approach and unwavering determination.

Dr.Camel's Conclusion

This study provides valuable insights into the complex world of ovarian cancer treatment. It emphasizes the importance of individualized approaches, considering the unique characteristics of the disease and patient response. It's a reminder that even in the face of challenging conditions, hope and innovative solutions can pave the way for better outcomes.
Date :
  1. Date Completed 1976-06-02
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

1254157

DOI: Digital Object Identifier

1254157

SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.